Edge Therapies in Demand

Virionyx – the NZ company behind an experimental new AIDS drug – has been hired by two US organisations to develop therapies for diseases such as SARS. Said PM Helen Clark, at the opening of Virionyx’s new Mangere headquarters; “These developments at Virionyx are a significant step for the NZ biotechnology industry and one that will boost its international profile.” Virionyx is to develop antibody and antiviral treatments for SARS, West Nile virus, dengue fever, smallpox, anthrax, plague, tularaemia, and botulism for the Hauptman-Woodward Medical Research Institute and ZeptoMetrix biotechnology firm.


Tags: AIDS drug  anthrax  China Daily  Hauptman-Woodward Medical Research Institute  Helen Clark  Mangere  New Zealand  NZ biotechnology industry  People's Daily  SARS  smallpox  United States  Virionyx  West Nile virus  ZeptoMetrix  

New Zealand Signs Space Agreement with NASA

New Zealand Signs Space Agreement with NASA

New Zealand has announced it is the latest country to sign a space agreement with NASA, just as the country’s nascent space industry begins to take off, Associated Press correspondent Nick Perry…